ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Kidney transplantation"

  • 2015 American Transplant Congress

    Outcomes of Live Kidney Donors Who Develop End Stage Renal Disease

    A. Muzaale, A. Massie, L. Kucirka, D. Segev.

    Johns Hopkins, Baltimore.

    Kidney donors can develop ESRD after donation, but the outcomes of those who do remain poorly characterized.Methods: Using USRDS and SRTR data, we compared access…
  • 2015 American Transplant Congress

    ASKP1240 in De Novo Kidney Transplant Recipients

    R. Harland,1 G. Klintmalm,2 H. Yang,3 S. Jensik,4 T. Shah,5 P. West-Thielke,6 F. Shihab,7 W. Zhang,8 V. Santos,8 R. Tainaka,8 X. Wang,8 R. First,8 J. Holman.8

    1East Carolina University, Greenville, NC; 2Baylor University Medical Center, Dallas, TX; 3Pinnacle Health System, Harrisburg, PA; 4Rush University, Chicago, IL; 5Transplant Research Institute, Los Angeles, CA; 6University of Illinois Chicago, Chicago, IL; 7University of Utah Health Science Center, Salt Lake City, UT; 8Astellas Pharma Global Development, Northbrook, IL.

    Primary objective was to evaluate the efficacy and safety of ASKP1240, antagonistic anti-CD40 antibody, in either a CNI free regimen or a CNI minimization regimen…
  • 2015 American Transplant Congress

    Evaluation of the Use of Leflunomide for the Prevention of BK Nephropathy in Renal Transplant Recipients- A Single Center Experience

    S. Jonchhe, E. Hollinger, S. Jensik, O. Olaitan, A. Hodowanec, M. Hertl, S. Fayek, E. Chan, C. Pullum, N. Alvey.

    Rush University Medical Center, Chicago, IL.

    Objective: The purpose of this study was to compare the efficacy of leflunomide in combination with reduced immunosuppression versus reduction of immunosuppression alone for the…
  • 2015 American Transplant Congress

    An Investigation of 12 Cases of Membranous Nephropathy of the Donor Origin Accidentally Detected by 0-h Renal Biopsy During Kidney Transplantation

    K. Unagami,1 D. Toki,1 M. Okumi,1 H. Ishigooka,1 K. Tsujimura,1 T. Kanzawa,1 K. Omoto,1 H. Ishida,1 K. Nitta,2 K. Tanabe.1

    1Urology, Tokyo Women's Medical University, Shinjuku-ku, Tokyo, Japan; 2Nephrology, Tokyo Women's Medical University, Shinjuku-ku, Tokyo, Japan.

    Membranous Nephropathy (MN) is a type of glomerulonephritis characterized by thickening of the glomerular basement membrane with immunoglobulin deposition. Proteinuria is a primary symptom, and…
  • 2015 American Transplant Congress

    Are AT1R Antibodies as Dangerous as HLA-DSAs in Renal Allografts?

    E. Cuevas, J. Arreola-Guerra, E. Hernandez-Mendez, I. Salcedo, M. Vilatoba, A. Contreras, A. Sanchez-Cedillo, J. Ramirez, D. de Rungs, J. Granados, L. Morales-Buenrostro, J. Alberu.

    1Transplantation, 1aNephrology-Mineral Metabolism, Inst Nal de Ciencias Medicas y Nutricion SZ, Mexico City, Distrito Federal, Mexico.

    Angiotensin II type 1 receptor antibodies (AT1Rab) have been associated with a significantly lower graft survival and a higher risk of acute rejection after kidney…
  • 2015 American Transplant Congress

    Eculizumab in the Treatment of Early Severe Acute Antibody Mediated Rejection Following HLA-Compatible Kidney Transplantation-Case Series

    M. Singh,1 N. Macias,2 V. Tatapudi,1 B. Lee.1

    1Transplant Nephrology, UCSF Medical Center, San Francisco, CA; 2Nephrology, Hospital Gregorio Maranon, Madrid, Spain.

    Severe early acute antibody-mediated rejection (AMR) is associated with poor allograft outcomes. Eculizumab is a humanized mouse monoclonal antibody against complement factor C5 that has…
  • 2015 American Transplant Congress

    A Novel Maintenance Regimen With Calcineurin Inhibitor, MMF and Everolimus Initiated By Dual Induction Therapy With Anti-CD20/25 Antibodies in Renal Transplantation

    N. Masaki, K. Iwado, I. Nakagima, S. Fuchinoue.

    Surgery III, Tokyo Women's Medical University Hospital, Shinjuku-ku,Tokyo, Japan.

    【background】Calcineurin inhibitor (CNI), MMF and steroid has been the gold standard of maintenance regimen in renal transplantation (RTx). A line of new immunosuppressants has emerged…
  • 2015 American Transplant Congress

    Pre-Transplant Weight Change and New-Onset Diabetes After Kidney Transplantation

    E. Huang, B. Abdalla, M. Andre, S. Bunnapradist.

    Dept of Medicine, UCLA School of Medicine, Los Angeles, CA.

    Background:We studied the association between pre-transplant weight change and new-onset diabetes after kidney transplant (NODAT).Methods:Using OPTN/UNOS data with follow-up to October, 2012, all adult (age>18…
  • 2015 American Transplant Congress

    Incidence, Determinants and Outcome of Kidney Transplantation for End Stage Renal Disease After Heart Transplantation

    A. Grupper,1 A. Grupper,1 R. Daly,1 M. Hathcock,2 W. Kremers,2 F. Cosio,1 B. Edwards,1 S. Kushwaha.1

    1William J. von Liebig Transplant Center, Mayo Clinic, Rochester, MN; 2Division of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, MN.

    Objectives: Progressive renal failure is a frequent complication following heart transplantation (HTx), is generally attributed to calcineurin inhibitor (CNI) based immunosuppression, and may result in…
  • 2015 American Transplant Congress

    Gradual Warming Up Perfusion Post Static Cold Storage Reduces Renal Injury

    P. Mahboub,3,1 P. Ottens,1 R. Ploeg,2 P. Martins,3 H. Leuvenink.1

    1Surgery, UMCG, Groningen, Netherlands; 2Surgery, University of Oxford, Oxford, United Kingdom; 3Surgery, UMass, Worcester, MA.

    We hypothesize that the sudden warm reperfusion after Cold Storage [CS] is detrimental for the graft and we therefore evaluated different warming-up procedures before reperfusion.Methods:Rat…
  • « Previous Page
  • 1
  • …
  • 480
  • 481
  • 482
  • 483
  • 484
  • …
  • 531
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences